Two tools tested to tell brain tumor from healthy tissue during surgery
Original title: Integrating Confocal Laser Endomicroscopy and Label-Free Nanoplasmonic Biosensing for Intraoperative Glioblastoma Tissue Discrimination - A hypothesis generating study.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This was tested on tissue samples from patients, not yet used to guide surgery.
The short version
Doctors tried two tools to help find where a brain tumor ends during surgery.
What was studied. Doctors took 45 pairs of tissue samples during brain surgery for glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary. They tested a light sensor on all pairs and a tiny camera on 14.
What they found. The sensor spotted tumor tissue 88% of the time. On tissue that was not tumor, it was right only 41% of the time. Overall it was correct 68% of the time. The tiny camera agreed with the lab tests in 86% of its pairs.
What this means, and what it doesn't
What it could mean: Better tools could help surgeons see where a tumor stops. That may help them take out more tumor and less healthy brain. This study is an early step toward that.
What it doesn't mean: This does not mean a new test is ready for your surgery. The tools were tried on tissue samples, not used to guide an operation. The sensor was often wrong about tissue that was not tumor. The authors call this early work meant to raise ideas, not prove them. It is not a treatment and not a cure.
Source: PubMed, August 14, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.